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Summary 
The splenic marginal zone (MGZ), which surrounds the mantle zone (MTZ) in human splenic 
white pulp, contains a phenotypically and morphologically distinct population of B cells. The 
origin of MGZ B cells is .uncertain.  Whereas some experiments in rodents have suggested that 
they are a distinct cell lineage responsible for the immune response to T-independent type 2 an- 
tigens, others have suggested that they are memory B cells derived from a germinal center (GC) 
response. The progeny of a GC reaction is expected to have rearranged immunoglobulin (Ig) 
genes that are mutated. The distribution of mutations would be expected to reflect the selection 
of Ig by its affinity for antigen. We have analyzed rearranged Ig heavy chain variable region 
(VH) 6 and VH 4.21  genes in MGZ and MTZ B cells microdissected from frozen sections of 
human spleen to determine whether these genes have the properties of an affinity-selected  memory 
B cell population.  MTZ B cells contained germline Ig VH genes, confirming previous reports 
and providing an internal control for mutational analysis. MGZ B cells contained Ig VH genes 
that were mutated, showing that these cells had been subjected to a mutational mechanism charac- 
teristically active in the GC.  The rearranged VH 6 genes showed patterns of mutation indica- 
tive of an antigen selection process,  whereas the distribution of mutations in VH 4.21  genes 
was not characteristic of gene selection by conventional T-dependent antigen. Our studies pro- 
vide the first evidence that the human splenic MGZ is a reservoir of memory B cells. 
T 
he marginal zone (MGZ) l of the spleen is a microana- 
tomically defined lymphoid compartment at the border 
of the white and red pulp.  The major cellular components 
of the MGZ are B cells and macrophages (1-3). In humans 
and rodents, MGZ B cells are characteristically IgM + , IgD-, 
and they strongly express CD21  (1, 4-6).  They are not in 
cell cycle and do not express antigens associated with cellular 
activation (7,  8). 
Two different functions have been ascribed to MGZ B cells 
in rodents: the antibody response to T-independent type 2 
(TI-2)  antigens  and  B  cell  memory.  It  has  been  well 
documented that an intact splenic MGZ is required for an 
efficient response to TI-2 antigen (9-11).  A  number of ex- 
periments have suggested that the B cells in the MGZ (12) 
and the B cells responding to TI-2 antigens (13) differ de- 
velopmentally from other B cell populations, and they have 
prompted the suggestion that MGZ B ceUs are of a distinct 
1 Abbreviations used in this paper: Fw, framework  region; GC, germinal 
center; MGZ, marginal zone; MTZ, mantle zone; R, replacement;  s, si- 
lent; TD, T dependent; TI-2, T independent type 2; Vs, heavy  chain 
variable region. 
lineage. However, in vitro comparison of the ability of mu- 
fine MGZ B cells and follicle center B cells to respond to 
T-dependent (TD),  TI-1,  and TI-2 antigens have failed to 
show any major differences, suggesting that responsiveness 
to TI-2 antigens is due to factor(s) in the microenvironment 
of the MGZ (14). The role of MGZ macrophages in the re- 
sponse of MGZ B cells  to TI-2 antigens has not yet been 
resolved. Although MGZ macrophages sequester TI-2 an- 
tigens (3), the possibility that this function is one of antigen 
elimination only has not been excluded (15,  16). 
Evidence that memory B cells reside in the splenic MGZ 
is derived from experiments in rats using immunocytochem- 
istry to follow the migration of hapten-specific B cells. These 
cells localize in the MGZ after primary antigen challenge and 
selectively migrate out of the MGZ in response to the appro- 
priate secondary challenge (7). 
Less is known of the properties of MGZ B cells in humans, 
although there is circumstantial evidence linking human MGZ 
B cells with the response to TI-2 antigens. Splenectomized 
patients have an impaired antibody response to TI-2 antigens 
(17). Also, the response to TI-2 antigens in newborns and 
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Volume 182  August 1995  559-566 Figure  1.  Serial  sections of spleen immunohistochemically stained to identify IgD + MTZ B cells (brown). Microdissected areas of (A) MGZ, and 
(B) MTZ cells are illustrated. The location of MGZ (MG), MTZ (MT), T cell area (T), and red pulp (R) are indicated. Original magnification: 50. 
infants up to the age of two is limited; this corresponds with 
the age at which a fully developed MGZ is seen (18).  Other 
than the supporting observation that MGZ B cells accumu- 
late over the first years of life (18), there is no published evi- 
dence that the human MGZ is a reservoir of memory B cells. 
Memory B cells are the progeny of a germinal center (GC) 
response to TD  antigens.  In the GC,  Ig genes  are somati- 
cally mutated, and the B cells expressing the mutated Ig genes 
560  Human Marginal Zone B Cells are Memory Cells are subsequently selected for high affinity binding to antigen 
(19). Hence, memory cells are expected to have mutated Ig 
heavy chain variable region (VH)  genes reflecting this  pro- 
cess (19-21). In this study, we have sequenced rearranged Ig 
genes from microdissected MGZ and mantle zone (MTZ) B 
cells.  We studied Via 4.21 and Via 6 because these are highly 
conserved genes  (22),  enabling  comparison with  germline 
sequence without the problem of discriminating between mu- 
tation and polymorphic variation. We have observed that MGZ 
but not MTZ B cells have mutated Ig genes. Human MGZ 
B cells have therefore been through a GC response, and the 
majority are likely to be memory B  cells. 
Materials  and  Methods 
Normal Human Splenic Tissue.  Normal splenic tissue from a 36- 
yr-old male (patient A) and from a 41-yr-old  female  (patient B) 
was removed during pancreatectomy. The tissue was snap frozen 
in liquid nitrogen soon after surgery. 
Immunohistochemistry and Microdissection.  7-/~m,  serial, frozen 
sections  were prepared and kept at -20~  for use within 24 h. 
Sections were stained as previously described (23) using mAbs L26 
(CD20), DRC1 (follicular dendritic cells), IgD, UCHT1 (CD3), 
and 9G4 (VH 4.21 + cells).  All antibodies,  with the exception of 
9G4, were obtained from Dako (High Wycombe, Bucks, UK). 9G4 
was kindly provided by Dr. F. K. Stevenson (Tenovus Laboratory, 
Southampton,  UK). 
After staining,  the sections were left unmounted at room tem- 
perature overnight to air dry. Stained serial sections were examined 
to determine the distribution of MGZ and MTZ B cells. Both are 
CD20 +, but only MTZ B cells are IgD +. All areas of white pulp 
studied contained GC, but these were not always cut through in 
the sections used for microdissection. Approximately 20-40 cells 
from either the MGZ or MTZ were then dissected from IgD-stained 
sections (Fig.  1). Microdissection was performed under 50% eth- 
anol using glass capillary  tubing with a Leitz micromanipulator 
(Leica UK Ltd., Milton Keynes, Bucks,  UK). The samples were 
collected in 0.6-ml Eppendorf tubes and allowed to dry at room 
temperature overnight. 
Preparation of Samples for  PCR.  DNA  was  released  from 
microdissected samples by treating with 10/~1 of a solution con- 
taining proteinase K at 200/xg/ml in lx  Taq polymerase buffer 
(Promega, Southampton, UK) at 37~  for 48 h. The proteinase 
K was inactivated at 95~  for 10 min and 5 #1 of the resulting 
solution was  used for PCIL. 
PCR.  All reactions were performed using a PCR machine (Om- 
nigene;  Hybaid,  Teddington,  UK).  To  amplify  Ig  VH-DH-JH 
regions for cloning and sequencing,  nested PCR reactions were 
performed, amplifying "~350 bp of rearranged H chain genes, from 
framework one (Fwl) to JH. In the first reaction, leader region 5' 
primers for a VH 6 or a VH 4, family-specific, consensus  sequence 
were used,  together with a 3' Jrt region primer, JrfA,  5'-ACC- 
TGAGGAGACGGTGACCAGGGT-3'  (25).  "Hot  start"  PCR 
amplification was carried out as previously described (23),  using 
5/zl of DNA sample. Optimal concentrations of MgC12 used were 
3.5  mM for VH 6 and 1.35 #M for VH family 4. Denaturation, 
annealing,  and extension phases were carried out at 94~  for 40 
s, 65~  for 45 s, and 72~  for 2 min,  respectively.  30 cycles of 
PCR were performed, followed by a final elongation step of 10 
min at 72~ 
The nested reaction was performed with a Fwl primer specific 
for either the VH 6 gene (5'-CCTGTGCCATCTCCGGGGACA- 
GTG-3')  or  the  Vr~  4.21  gene  (5'-AGCTACAGCAGTGGG- 
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GCG-Y), together with a JH region 3' primer, situated upstream 
of the first Jrf region primer (j'HB, 5'-GTGACCAGGGTACCT- 
TGGCCCCAG-Y) (26). Of the first round PCIL products, 2/~1 
was amplified  as above, using a concentration of 1.5 mM MgC12 
and  with  an  annealing  temperature of 55~  The success and 
specificity of the reaction were checked by running 15/xl of the 
final PCR products on a 3.5% agarose gel (Nusieve; Flowgen In- 
struments Ltd., Sittingbourne, UK) and visualizing using ethidium 
bromide. 
Cloning and Sequencing.  PCR products were end filled with 
Khnow (Promega), purified, and cloned into the vector pCR-Script 
SK(+) using Wizard Preps (Promega) and the pCR-Script cloning 
method (Stratagene Ltd., Cambridge, UK) as previously described 
(23). Before preparation for sequencing, plasmids were checked for 
correct insert size by PCR. A small sample of each clone was boiled 
in 10 #1 water, and 1 #1 of this was amplified  using T3 and T7 
primers under standard conditions using 30 cycles of PCR with 
an annealing temperature of 45~  Of the products,  10/~1 was 
checked on agarose gels, and 5-/xl aliquots of the remainder were 
used for sequencing. 
Clones were sequenced  in both directions using a sequencing 
kit (Sequenase;  Amersham International, Little Chalfont,  UK). 
PCR products were prepared for sequencing by sequential treat- 
ment with exonuclease I and shrimp alkaline phosphatase, as recom- 
mended in the Sequenase  protocol. 
Analysis  of sequences  was  performed using  GCG  software 
(Genetics Computer Group, Madison, WI). PCR error was calcu- 
lated by sequencing a number of different clones of the same gene 
(as determined by comparison of CDR3 regions). The PCR error 
rate for these methods was found to be <0.2%. Where possible, 
mutations in each gene were checked by sequencing another clone 
of the same gene. Calculations of whether mutations were random 
or selected were performed according to the following formula: 
Expected number of replacement (R) (or silent  [s]) mutations in 
a particular region  =  total number of mutations  x  proportion 
of total sequence in the region  x  the expected proportion of R 
(or s) for that region. The values for the expected proportion of 
R or s mutations in CDR regions were taken to be 0.805 and 0.195, 
respectively, while those expected for the Fw regions were taken 
to be 0.739 and 0.261,  respectively (27). 
Results and Discussion 
Microdissection and PCR of Tissue.  Successful PCR with 
both VH 4.21 and V8 6 primer sets yielded clear amplifica- 
tion products of "~320 bp with no contaminating product, 
allowing cloning without prior purification. Of the 21 differ- 
ent microdissected samples used for VH 4.21 amplification, 
19 were successfully amplified. However, only 15 successful 
amplifications of Via 6 genes were obtained from 44 different 
microdissected samples.  This success rate of only 38%  is a 
likely consequence of the infrequent VH 6 gene usage in the 
adult B cell population (28). Agarose electrophoresis of PCR 
products yielded multiple  bands  of the VH  4.21  gene but 
usually only a single band of the Via 6 gene, again reflecting 
the relative frequency of gene usage. As a consequence, mul- 
tiple copies of Via  6  genes from the  same microdissection 
were cloned, allowing PCR error to be eliminated from the 
sequence analysis. However, the Via 4.21 clones from single 
microdissections were variable,  and  multiple clone analysis 
of a  single  gene was  not  always possible. 
MGZ Ig  VH 6 Genes Are Mutated.  A  total of 31 Via  6 VH6 
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Figure  2.  Comparison of Ig VH 6 genes from splenic MGZ and MTZ B cells. The germline VH6 sequence, numbering of codons,  and position 
of CDRs (bold type) are as published by Tomlinson et al. (24). Codons unmutated from germline are not shown. Identity with the gennline sequence 
is represented by dashes, replacement mutations  are represented by uppercase letters, and silent mutations are represented by lowercase letters. The 
source of the B cells from which the Ig genes were amplified is shown, with A and B indicating two different spleens. In-frame VH 6 genes, which 
are likely to be from the expressed allde,  are marked in the Frame column as IN; others are marked OUT and/or S (terminated). Where more than 
one copy of each gene was sequenced, the number of multiple clones is shown. These sequence data are available from EMBL under accession numbers 
X84172-X84178  and X84186-X84192. 
clones were sequenced, representing seven different rearranged 
Ig V.  genes from each of the MGZ  and MTZ  (Fig.  2).  Mul- 
tiple copies of single rearranged genes were identified by com- 
parison of their CDR3  region sequences  (sequence data not 
shown).  Of these rearranged genes,  50%  are probably from 
unexpressed  alleles,  as their VH regions are either not in the 
same reading  frame as the JH regions,  or they contain  a ter- 
mination  codon  in  CDR3  (Fig.  2).  These  are  included  in 
the results, as the somatic mutation process, if occurring, affects 
both alleles (29).  The in-frame rearrangements,  with no ter- 
mination codons in CDR3,  are probably expressed alleles (30). 
Most  MTZ  Ig VH sequences  (MT6-1  to MT6-7)  are un- 
mutated,  although two of these clones, MT6-3  and MT6-6, 
do have a single silent mutation each (Fig.  2).  These are not 
likely to be an artifact of the PCR process, as both these mu- 
tations have been identified in two separate clones. This result 
confirms  that  the Viq  6  genes  from  the individuals  studied 
do not vary from published  germline  sequences.  The germ- 
line configuration  of Ig VH 6  genes in MTZ  B  cells is con- 
sistent with other studies showing that MTZ B cells are virgin 
B  cells  (29).  Of  the  seven  MGZ  gene  rearrangements  se- 
quenced,  one  (MG6-7)  did  not  show  any mutations.  Mul- 
tiple clone analysis was not possible  for this gene;  hence,  it 
Figure  3.  Comparison of the mean number of observed replacement 
mutations for in-frame MGZ Ig VH 6 gene regions with the mean number 
expected for equivalent randomly mutated sequences. 
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Figure  4.  Comparison  of Ig VH 4.21 genes from splenic MGZ and MTZ B cells. The germline VH 4.21 sequence, numbering  of codons, and posi- 
tion of CDKs (bold type) are as published by Tomlinson et al. (24). Codons unmutated from germline are not shown. Identity with the germline 
sequence  is represented  by dashes, replacement  mutations  by uppercase  letters, and silent mutations  by lowercase letters. Clone MG4-9 has large deletions, 
which are left blank. The source of the B cells from which the Ig genes were amplified is shown, with A and B indicating two different spleens. 
In-frame VH 4.21 genes that are likely to be from the expressed allele are marked in the Frame column as IN; others are marked OUT and/or S (termi- 
nated). Those not marked could not be designated IN or OUT because of poor quality of the CDR3 sequence. Where more than one copy of each 
gene was sequenced, the number of multiple clones is shown. These sequence  data are available  from EMBL under  accession numbers X84163-X84171 
and X84179-X84185. 
is not clear  whether this is significant.  The remaining six 
gene rearrangements had heavily mutated VH 6  genes, and 
all mutations were confirmed by multiple clone analysis (Fig. 
2). This is the first evidence that human MGZ B cells have 
been subjected to  somatic mutation. 
Vn 6 Ig Genes from MGZ Show Characteristics of Antigen 
Selection.  Out-of-frame  Ig gene rearrangements,  or those 
with termination codons in CDP,3, have not been used when 
considering whether the distribution of mutations in Ig VH 
6  genes resembles  that expected from Ig genes  in affinity- 
matured B  cells.  Analysis of the distribution of mutations 
in the remaining sequences (MG6-1 to MG6-4) shows that 
a higher number of replacement mutations is observed in the 
CDRs and a lower number of replacement mutations is ob- 
served in the Fw regions than would be expected if the genes 
had been randomly mutated with no selective pressure  (Figs. 
2 and 3). Therefore, it can be concluded that Ig VH 6 genes 
from MGZ B cells have patterns of mutation indicating se- 
lection by antigen in the GC.  In light of these findings, it 
is likely that the MGZ B cells containing these Ig genes are 
memory B  cells. 
MGZ Ig Vu 4.21 Genes Are Mutated.  A  total of 20 VH 
4.21 clones were sequenced, representing nine different rear- 
ranged genes from the MGZ and seven from the MTZ. No 
V58 sequences, which could also be amplified with the Fwl 
primer used, were observed.  Of the 20 VH 4.21 sequences, 
50% were dearly in frame,  with no termination codons in 
CDR3.  These are therefore considered to be the expressed 
allele.  Of the seven MTZ sequences,  five were identical to 
the published germline VH 4.21  sequence (Fig.  4).  Again, 
this agrees  with previously published findings that B  cells 
from the MTZ are virgin B cells.  The number of repeat  se- 
quences from different clones was limited; therefore,  the pos- 
sibility of PCK error  as a cause of the single replacement 
563  Dunn-Wahers  et al. Figure  5.  Comparison  of the mean number of observed replacement 
mutations for in-frame MGZ Ig VH 4.21 gene regions with the mean 
number expected for equivalent randomly mutated sequences. 
mutations  seen in clones MT4-5 and MT4-7 cannot be dis- 
counted. All nine of the MGZ genes were mutated, and seven 
had  two or more mutations  (Fig.  4). 
Clones MG4-4 and MG4-5 have a different sequence from 
Fwl to CDR2 but have the same CDR3 and Fw3 regions 
(Fig. 4). It is possible that these sequences are clonally related. 
However, if the shared mutation in Fw2 codon 40 is consid- 
ered to be coincidental, then the apparent relatedness of these 
dones would be more likely to be due to a PCR hybrid artifact. 
Ig VH 4.21 Genes  from MGZ Do Not Show Characteristic 
Evidence of Antigen  Selection.  The  distribution  of replace- 
ment  mutations  was analyzed in  the clones likely to be of 
expressed alleles,  MG4-1  to MG4-6.  In contrast  to the VH 
6  genes,  the frequency of replacement  mutations  observed 
in Fw2 and Fw3 of VH 4.21 was the same as or higher than 
would be expected, and the frequency of replacement muta- 
tions  in  CDR2  was lower than  would be expected,  if the 
acquisition of the mutations  were random  and the popula- 
tion were under no selective pressure (Fig. 5). These regions, 
therefore, do not have the distribution of mutations charac- 
teristically  acquired  during  affinity  maturation.  However, 
CDR1 does have more replacement  mutations  than  would 
be expected and Fwl has less mutations  than would be ex- 
pected if the process were random,  under no selective pres- 
sure.  The  presence  of mutated  Vrt  4.21  sequences  in  the 
MGZ B cells suggests that they have been subjected to a muta- 
tional mechanism  characteristically active in the GC. How- 
ever, in contrast with the rearranged VH 6 genes from MGZ 
B cells,  there is little evidence of the conventional TD  an- 
tigen  selection of VH 4.21  genes with  variable CDRs and 
intact Fw regions that would normally be expected in the GC. 
It is unlikely that cells using Ig VH 4.21 genes would un- 
dergo  mutation  in  the  GC  reaction  and  differentiate  into 
memory B cells without having been through a selection pro- 
cess.  If antigen  has  been involved in  the selection of these 
VH 4.21-containing  cells,  it is not likely to be in the con- 
ventional  manner.  It  has  been  suggested  that  Ig VH 4.21 
may bind a putative B cell superantigen (Ig-sAg) (31). Cold 
agglutinin antibodies with I/i spedficity all use VH 4.21 but 
have widely varied DH, JH,  and L chain genes (32,  33).  In 
conventional Ag-antibody interactions, it is generally agreed 
that all these factors combine to produce specificity (30). How- 
ever,  a known Ig-sAg,  Staphylococcus aureus protein A,  has 
been shown to bind to Vr~ 3 family genes in Fw region (34) 
rather  than  the  CDRs.  If  B  cells  using  VH  4.21  bind 
Ig-sAg, then they would not be expected to acquire the same 
patterns of mutation in CDRs and Fw regions of the Ig VH 
genes as observed in the conventional GC response to TD 
Ag. Interestingly,  the Fwl region of VH 4.21 was found to 
be conserved in  this  study. 
The  presence of mutated  VH genes  in  the  MGZ B  cell 
population,  which is mainly IgM §  does not concur with 
the general idea that  memory cells are isotype switched.  B 
cells expressing IgA and IgG are present  in the MGZ, but 
only as relatively minor components (1, 35). Mutated IgVr~ 
and IgVL sequences from IgM + cells have been observed by 
others (36-39) and also are considered to be associated with 
an IgM +, IgD-  B cell subset (39). Evidence to support the 
idea that  somatic mutation and isotype switching are sepa- 
rate  events  in  the  GC,  with  some  mutation  of V  genes 
preceding isotype switching,  has been derived from a study 
of clonally related genes that  use different constant regions 
(including C/z) and that show progressive somatic mutation 
(40).  This,  together with data presented here, would imply 
that  the MGZ harbors mainly early memory B cells. How- 
ever, it has also been suggested that IgM + memory cells may 
be responsive to a particular group of antigens or that  they 
could represent a distinct pathway of memory B cell devel- 
opment  (38,  39). These ideas  may be relevant,  considering 
the distinctive functional properties ascribed to the MGZ in 
earlier  studies. 
Conclusions.  MGZ  B  cells  have  mutated  Ig  V.  genes, 
whereas MTZ B cells do not.  This is the first evidence that 
human MGZ B cells are memory B cells. The VH 6 Ig genes 
studied showed the characteristic  pattern of mutation expected 
from an antigen-selected product of a GC reaction.  Vr~ 4.21 
genes, however, did not exhibit a conventional pattern of mu- 
tation. 
We are grateful  to T. C. Diss for providing  some of the PCR primers and to Dr.  F. K. Stevenson and 
Dr. C. J. Chapman  for their invaluable advice and for providing the monoclonal antibody, 9G4. We are 
also grateful  to Professor T.  T. MacDonald  for the use of the Leitz micromanipulator. 
564  Human  Marginal Zone B Cells are Memory Cells This work was  supported by the Leukemia  Research Fund. 
Address correspondence to Dr. Jo Spencer, Department of Histopathology, University College London 
Medical School, Rockefeller Building, University Street, London WC1E 6JJ,  UK. 
Received for publication 13 February 1995 and in  revised  form 20 March  1995. 
References 
1.  Timens, W., and S. Poppema. 1985. Lymphocyte  compartments 
in human spleen. An immunohistologic study in normal spleens 
and uninvolved spleens in Hodgkin's disease. Am. J. Pathol. 
120:443-454. 
2.  Kumararatne,  D.S., H. Bazin, and I.C. MacLennan.  1981. Mar- 
ginal zones: the major B cell compartment of rat spleens. Eur. 
J. Immunol. 11:858-864. 
3.  Humphrey, J.H., and D. Grennan. 1981. Different macrophage 
populations distinguished by means of fluorescent polysaccha- 
rides.  Recognition and properties of marginal-zone macro- 
phages.  Eur. J. Immunol. 11:221-228. 
4.  Gray, D., I.C. MacLennan, H. Bazin, and M. Khan. 1982. Mi- 
grant mu + delta + and static mu * delta- B lymphocyte sub- 
sets. Eur. j. Immunol. 12:564-569. 
5.  Gray, D., I. McConnell, D.S. Kumararatne, I.C. MacLennan, 
J.H. Humphrey, and H. Bazin. 1984. Marginal zone B cells 
express CR1 and CR2 receptors. Eur.  J. Immunol. 14:47-52. 
6.  Timens, W., A. Boes,  and S. Poppema.  1989.  Human mar- 
ginal zone B cells are not an activated B cell subset: strong 
expression of CD21 as a putative mediator for rapid B cell acti- 
vation. Eur. j. Immunol. 19:2163-2166. 
7.  Liu, Y.J.,  S. Oldfield, and I.C. MacLennan.  1988.  Memory 
B cells in T  cell-dependent antibody responses  colonize the 
splenic  marginal zones.  Eur. J. Immunol. 18:355-362. 
8.  MacLennan,  I.C., Y.J. Liu, S. Oldfield, J. Zhang, and P.J. Lane. 
1990. The evolution of B-cell clones. Cu~  Top. Microbiol. Im- 
munol. 159:37-63. 
9.  Lane, P.J.,  D. Gray, S. Oldfield, and I.C. MacLennan. 1986. 
Differences in the recruitment of virgin B cells into antibody 
responses to thymus-dependent and thymus-independent  type-2 
antigens. Eur. J. Immunol. 16:1569-1575. 
10.  Bazin, H., D. Gray, B. Platteau, and I.C. MacLennan. 1982. 
Distinct delta + and delta- B-lymphocyte lineages in the rat. 
Ann. NY Acad. Sci. 399:157-174. 
11.  Amlot, P.L., D. Grennan, and J.H. Humphrey. 1985. Splenic 
dependence of the antibody response to thymus-independent 
(TI-2) antigens. Eur. j. Immunol. 15:508-512. 
12.  MacLennan, I.C.,  and D. Gray.  1986.  Antigen-driven selec- 
tion of virgin and memory B cells. Immunol. Rev. 91:61-85. 
13.  Whalen, B.J., and I. Goldschneider.  1993. Identification and 
characterization of B cell precursors in rat lymphoid tissues. 
I. Adoptive transfer assays for precursors of TI-1, TI-2, and 
TD antigen-reactive B cells. Cell. Immunol. 151:168-186. 
14.  Snapper, C.M., H. Yamada, D. Smoot, R. Sneed, A. Lees, and 
J.J. Mond.  1993. Comparative in vitro analysis of prolifera- 
tion, Ig secretion, and Ig class switching by murine marginal 
zone and follicular  B cells. J. Immunol. 150:2737-2745. 
15.  Claassen,  E., N. Kors,  C.D. Dijkstra, and N. Van Rooijen. 
1986. Marginal zone of the spleen and the development and 
localization of specific antibody-forming cells against thymus- 
dependent and thymus-independent type-2 antigens. Immu- 
nology. 57:399-403. 
16.  van den Eertwegh, A.J., J.D. Laman, M.M. Schellekens, W.J. 
Boersma, and E. Claassen.  1992. Complement-mediated fol- 
licular localization of T-independent type-2 antigens: the role 
of marginal  zone  macrophages  revisited.  Eur. J.  Immunol. 
22:719-726. 
17.  Amlot,  P.L.,  and A.E.  Hayes.  1985.  Impaired human anti- 
body response to the thymus-independent antigen, DNP-Ficoll, 
after splenectomy. Implications for post-splenectomy infections. 
Lancet. i:1008-1011. 
18.  Timens,  W.,  A.  Boes,  T.  Rozeboom  Uiterwijk,  and  S. 
Poppema.  1989. Immaturity of the human splenic  marginal 
zone in infancy. Possible contribution to.the deficient infant 
immune response, j.  Immunol. 143:3200-3206. 
19.  Berek, C. 1993. Somatic mutation and memory. Cu~ Opin. 
Immunol. 5:218-222. 
20.  Tsiagbe, V.K., P.J. Linton, and G.J. Thorbecke. 1992. The path 
of memory B-cell development. Immunol. Rev. 126:113-141. 
21.  Pascual, V., Y.-J. Liu, A. Magalski,  O. de Bouteiller, J. Ban- 
chereau, and J.D. Capra. 1994. Analysis of somatic mutation 
in five B cell subsets of human tonsil.J. Extx Med. 180:329-339. 
22.  Sanz, I., P. Kelly,' C. Williams, S. Scholl, P. Tucker, and J.D. 
Capra. 1989. The smaller human VH gene families display re- 
markably little polymorphism. EMBO (Eur. Mol. Biol. Organ.) 
J.  8:3741-3748. 
23.  Dunn-Walters,  D.K., C.J. Howe, P.G. Isaacson, andJ. Spencer. 
1995. Location and sequence of rearranged immunoglobulin 
genes  in human thymus. Eur. J. Immunol. 25:513-519. 
24.  Tomlinson, I.M., G. Walter, J.D. Marks, M.B. Llewelyn, and 
G. Winter. 1992. The repertoire of human germline VH se- 
quences reveals about fifty groups of VH segments with differ- 
ent hypervariable  loops. J. Mol. Biol. 227:776-798. 
25.  Campbell, M.J., A.D. Zelenetz, S. Levy, and R. Levy. 1992. 
Use of family specific leader region primers for PCR amplifica- 
tion of the human heavy chain variable region gene repertoire. 
Mol. Immunol. 29:193-203. 
26.  Dearie,  M.,  and J.D.  Norton.  1991. Immunoglobulin gene 
'fingerprinting': an approach to analysis of B lymphoid clo- 
nality in lymphoproliferative disorders.  Br. J. Haematol. 77: 
274-281. 
27.  Chang,  B., and P. Casali.  1994. The CDR1  sequences  of a 
major proportion of human germline Ig VH genes are inher- 
ently susceptible  to amino acid replacement. Immunol. Today. 
15:367-373. 
28.  Van Es, J.H.,  F.M.  Raaphorst, M.J.  van Tol, F.H. Meyling, 
and T. Logtenberg. 1993. Expression pattern of the most JH- 
proximal human VH gene segment (VH6) in the B cell and 
antibody repertoire suggests a role of VH6-encoded IgM anti- 
bodies in early ontogeny. J. Immunol. 150:161-168. 
29.  Kuppers,  R., M. Zhao, M.L. Hansmann, and K. Rajewsky. 
1993. Tracing B cell development in human germinal centres 
by molecular analysis of single cells picked from histological 
sections.  EMBO (Eur. Mol. Biol. Organ.)  J.  12:4955-4967. 
30.  Schroeder,  H.W., and R.M.  Perlmutter. 1993. Development 
of the human antibody repertoire. In New Concepts in Im- 
565  Dunn-Walters  et al. munodeficiency Diseases.  S. Gupta and C. Griscelli,  editors. 
John Wiley & Sons Ltd., Chichester, UK. 3-25. 
31.  Goodglick, L., andJ. Braun. 1994. Revenge of the microbes. 
Superantigens of the T and B cell lineage. Am. J. Pathol. 144: 
623-636. 
32.  Pascual,  V.,  K.  Victor, M.  SpeUerberg,  T.J.  Hamblin,  F.K. 
Stevenson, andJ.D. Capra.  1992. VH restriction among human 
cold agglutinins. The VH4-21 gene segment is required to en- 
code anti-I and anti-i specificities.J.  Iramunol. 149:2337-2344. 
33.  Silberstein, L.E., L.C. Jefferies, J. Goldman, D. Friedman, J.S. 
Moore, P.C. Nowell, D. Roelcke, W. Pruzanski, J. Roudier, 
and G.J. Silverman. 1991. Variable region gene analysis of patho- 
logic human autoantibodies to the related i and I red blood 
cell antigens. Blood. 78:2372-2386. 
34.  Hillson, J.L., N.S. Karr, I.K. Oppliger, M. Mannik, and E.H. 
Sasso. 1993. The structural basis of germline-encoded VH3 
immunoglobulin binding to staphylococcal protein A.j. Exp. 
Med. 178:331-336. 
35.  Smith-Ravin, J., J. Spencer, P.C.L. Beverley, and P.G. Isaacson. 
1990. Characterisation of two monoclonal antibodies (UCL- 
4D12 and UCL3D3) that discriminate between human mantle 
zone and marginal zone B cells. Clin. Exit lmmunoL 82:181-187. 
36.  Huang, C., A.K. Stewart, R.S. Schwartz, and RD. Stollar. 
1992. Immunoglobulin heavy chain gene expression in periph- 
eral blood lymphocytes, f  Clin. Invest. 89:1331-1343. 
37.  Ebeling, S.B., M.E.M. Schutte, and T. Logtenberg. 1993. Pe- 
ripheral human CD5 + and CD5- B cells may express somat- 
icaUy mutated VH5- and VH6-encoded IgM receptors.f Ira- 
munol. 151:6891-6899. 
38.  van Es, J.H., F.H.J. Gmelig-Meyling,  and T. Logtenberg. 1992. 
High frequency of somatically mutated IgM molecules in the 
human  adult  blood B cell repertoire. Fur. f  Immunol. 22: 
2761-2764. 
39.  Klein, U., K. Kuppers, and K. Rajewsky. 1993. Human IgM + 
IgD § B cells, the major B cell subset in peripheral blood, ex- 
press VK genes with little or no somatic mutation throughout 
life. Eur. f  Imraunol. 23:3272-3277. 
40.  Varade, W.S., and K.A. lnsel. 1993. Isolation ofgerminal cen- 
terlike events from human spleen RNA. Somatic hypermuta- 
tion of a clonally related VmDJ,  rearrangement expressed 
with IgM,  IgG, and IgA. f  Clin. Invest. 91:1838-1842. 
566  Human Marginal Zone B Cells are Memory Cells 